The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $267,669 in first-year total cost, median $267,669.
Most frequent study sections
- Special Emphasis Panel[ZRG1 EMNR-D (55)]1
Most frequent institutions
- NEXTGENJANE, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Developing a non-invasive, definitive diagnostic for endometriosis using biomarkers in menstrual effluence1R44HD103159-01 | GIRE, STEPHEN | NEXTGENJANE, INC., CA | $267,669 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.